Theravance Biopharma (TBPH) Stock Chart & Stock Price History → “The Stock Market’s Bull Run is Far from Over” -Barrons (From Vertical Research Advisory) (Ad) Free TBPH Stock Alerts $8.97 -0.04 (-0.44%) (As of 03/28/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Theravance Biopharma Stock Price Performance5 Day Performance+0.56%1 Month Performance-4.57%3 Month Performance-20.69%6 Month Performance+7.04%Year-To-Date Performance-20.20%1 Year Performance-15.22% Receive TBPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Theravance Biopharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Vertical Research Advisory“The Stock Market’s Bull Run is Far from Over” -BarronsBarron's reports that the "stock market's bull run is FAR from over…" And recent economic growth will fuel the price of select stocks in the coming months!Click here for all the details now… TBPH Stock Chart for Thursday, March, 28, 2024 TBPH Chart by TradingView Theravance Biopharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/28/2024$9.01$8.97-0.44%$9.00$8.77401,710 shs$432.09 million03/27/2024$8.82$9.01+2.15%$9.02$8.79320,008 shs$434.01 million03/26/2024$8.76$8.82+0.68%$8.95$8.75296,174 shs$424.86 million03/25/2024$8.92$8.76-1.79%$9.09$8.66365,377 shs$421.93 million03/22/2024$8.96$8.92-0.45%$8.98$8.83303,569 shs$429.68 million03/21/2024$9.01$8.96-0.55%$9.08$8.80364,078 shs$431.60 million Get the Latest News and Ratings for TBPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Theravance Biopharma and its competitors with MarketBeat's FREE daily newsletter. 03/20/2024$8.85$9.01+1.81%$9.03$8.70365,823 shs$434.01 million03/19/2024$8.65$8.85+2.31%$8.91$8.57495,636 shs$426.30 million03/18/2024$8.64$8.65+0.12%$8.80$8.54458,899 shs$416.67 million03/15/2024$8.61$8.64+0.35%$8.84$8.50899,346 shs$416.19 million03/14/2024$8.80$8.61-2.16%$9.26$8.55449,646 shs$414.74 million03/13/2024$8.52$8.80+3.29%$8.81$8.51358,683 shs$423.90 million03/12/2024$8.57$8.52-0.58%$8.65$8.45214,305 shs$410.41 million03/11/2024$8.62$8.57-0.58%$8.68$8.42272,101 shs$412.77 million03/08/2024$8.69$8.62-0.81%$8.85$8.52153,037 shs$415.23 million03/07/2024$8.74$8.69-0.57%$8.78$8.59262,859 shs$418.60 million03/06/2024$8.67$8.74+0.81%$8.83$8.68267,079 shs$421.01 million03/05/2024$9.10$8.67-4.73%$9.21$8.63309,276 shs$431.77 million03/04/2024$9.44$9.10-3.60%$9.44$9.09388,533 shs$453.18 million03/01/2024$9.47$9.44-0.32%$9.65$9.35242,748 shs$470.11 million02/29/2024$9.40$9.47+0.74%$9.66$9.44380,292 shs$471.61 million02/28/2024$9.69$9.40-2.99%$9.79$9.33263,644 shs$468.12 million02/27/2024$9.23$9.69+4.98%$10.11$9.03532,249 shs$482.56 million02/26/2024$8.98$9.23+2.78%$9.24$8.91225,345 shs$459.64 million02/23/2024$8.68$8.98+3.52%$8.98$8.54420,407 shs$447.20 million02/22/2024$8.76$8.68-0.97%$8.79$8.61280,433 shs$432.02 million02/21/2024$8.92$8.76-1.79%$8.98$8.63294,568 shs$436.25 million02/20/2024$8.80$8.92+1.36%$9.02$8.73334,650 shs$444.22 million02/19/2024$8.80$8.80$8.87$8.56346,900 shs$438.24 million02/16/2024$8.67$8.80+1.50%$8.87$8.56344,339 shs$438.22 million02/15/2024$8.46$8.67+2.48%$8.74$8.48273,752 shs$431.77 million02/14/2024$8.35$8.46+1.32%$8.49$8.29256,202 shs$421.31 million02/13/2024$8.58$8.35-2.68%$8.50$8.26471,781 shs$415.83 million02/12/2024$8.58$8.58$8.66$8.43257,557 shs$427.28 million02/09/2024$8.22$8.58+4.38%$8.60$8.28294,614 shs$427.28 million02/08/2024$8.50$8.22-3.29%$8.70$8.22734,240 shs$409.36 million02/07/2024$8.82$8.50-3.63%$8.86$8.50356,057 shs$423.30 million02/06/2024$8.85$8.82-0.34%$8.92$8.72274,296 shs$439.24 million02/05/2024$8.90$8.85-0.56%$8.91$8.64362,890 shs$440.73 million02/02/2024$9.16$8.90-2.84%$9.10$8.78361,055 shs$443.20 million“The Stock Market’s Bull Run is Far from Over” -Barrons (Ad)Barron's reports that the "stock market's bull run is FAR from over…" And recent economic growth will fuel the price of select stocks in the coming months!Click here for all the details now… 02/01/2024$9.48$9.16-3.38%$9.47$9.07362,515 shs$456.17 million01/31/2024$9.77$9.48-2.97%$9.86$9.48237,728 shs$472.10 million01/30/2024$10.03$9.77-2.59%$10.03$9.73281,488 shs$486.55 million01/29/2024$9.91$10.03+1.21%$10.04$9.81190,640 shs$499.49 million01/26/2024$9.91$9.91$10.03$9.76201,957 shs$493.52 million01/25/2024$9.81$9.91+1.02%$9.96$9.77276,699 shs$493.52 million01/24/2024$9.93$9.81-1.21%$10.07$9.79322,381 shs$488.54 million01/23/2024$9.66$9.93+2.80%$9.94$9.64407,403 shs$494.51 million01/22/2024$9.47$9.66+2.01%$9.67$9.48269,440 shs$481.07 million01/19/2024$9.52$9.47-0.53%$9.60$9.39202,823 shs$471.61 million01/18/2024$9.76$9.52-2.46%$9.72$9.44191,491 shs$474.10 million01/17/2024$9.63$9.76+1.35%$9.78$9.48253,604 shs$486.05 million01/16/2024$9.83$9.63-2.03%$10.08$9.60354,910 shs$479.57 million01/15/2024$9.83$9.83$10.04$9.70747,100 shs$489.53 million01/12/2024$9.78$9.83+0.51%$10.04$9.70747,111 shs$489.51 million01/11/2024$10.04$9.78-2.59%$10.02$9.75241,133 shs$487.04 million01/10/2024$10.05$10.04-0.10%$10.13$9.94267,378 shs$499.99 million01/09/2024$10.20$10.05-1.47%$10.29$9.91323,880 shs$500.49 million01/08/2024$10.37$10.20-1.64%$10.26$9.87655,001 shs$507.96 million01/05/2024$11.52$10.37-9.98%$10.87$10.091.43 million shs$516.43 million01/04/2024$11.59$11.52-0.60%$11.71$11.19249,325 shs$573.70 million01/03/2024$11.59$11.59$11.70$11.44453,890 shs$577.18 million01/02/2024$11.24$11.59+3.11%$11.68$11.10701,161 shs$577.16 million01/01/2024$11.24$11.24$11.37$11.21230,800 shs$559.75 million12/29/2023$11.31$11.24-0.62%$11.37$11.21230,868 shs$559.75 million12/28/2023$11.40$11.31-0.79%$11.48$11.23214,373 shs$563.22 million12/27/2023$11.24$11.40+1.42%$11.48$11.22335,241 shs$567.72 million Related Companies: TRDA Stock Price Chart OCS Stock Price Chart RVNC Stock Price Chart NUVB Stock Price Chart EPIX Stock Price Chart HRTX Stock Price Chart CDMO Stock Price Chart CRBP Stock Price Chart PEPG Stock Price Chart STTK Stock Price Chart Receive TBPH Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Theravance Biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TBPH) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Theravance Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.